Asthma and Chronic Obstructive Pulmonary Disease: Health Services
(asked on 16th December 2025) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the proportion of patients with asthma and chronic obstructive pulmonary disease receiving annual reviews.
Annual reviews, including reviews of medication, play a key role in the ongoing management of people with respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). They are recommended by the National Institute for Health and Care Excellence, as part of its guidance for the diagnosis and management of asthma and COPD
The majority of patients with COPD and asthma are managed by general practitioners and members of the primary care team. The provision of annual reviews is incentivised in primary care through the Quality and Outcomes Framework. There are indicators for annual reviews for both COPD, namely COPD010,and asthma, namely AST007, within this framework.
Further details on these indicators are available in the QOF guidance at the following link: